Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument.

Gupta V, Sreenivas V, Mehta M, Khaitan BK, Ramam M.

Br J Dermatol. 2014 Nov;171(5):1084-90. doi: 10.1111/bjd.13093. Epub 2014 Oct 6.

PMID:
24805089
2.

Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo.

Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S.

Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):205-10. doi: 10.4103/0378-6323.107637.

3.

Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL).

Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, Kundu RV.

J Am Acad Dermatol. 2013 Jul;69(1):e11-8. doi: 10.1016/j.jaad.2012.01.038. Epub 2012 Feb 25.

PMID:
22365883
4.

Identification of categories at risk for high quality of life impairment in patients with vitiligo.

Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L, Alessandroni L, Abeni D.

Br J Dermatol. 2008 Aug;159(2):351-9. doi: 10.1111/j.1365-2133.2008.08678.x. Epub 2008 Jun 28.

PMID:
18565189
5.

DLQI scores in vitiligo: reliability and validity of the Persian version.

Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY.

BMC Dermatol. 2004 Aug 4;4:8.

6.

Willingness-to-pay and quality of life in patients with vitiligo.

Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M.

Br J Dermatol. 2009 Jul;161(1):134-9. doi: 10.1111/j.1365-2133.2009.09091.x. Epub 2009 Mar 9.

PMID:
19298268
7.

Development and validation of a health-related quality of life instrument for women with melasma.

Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, Feldman SR, Chren MM.

Br J Dermatol. 2003 Sep;149(3):572-7.

PMID:
14510991
8.

Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre.

Kostopoulou P, Jouary T, Quintard B, Ezzedine K, Marques S, Boutchnei S, Taieb A.

Br J Dermatol. 2009 Jul;161(1):128-33. doi: 10.1111/j.1365-2133.2009.09077.x. Epub 2009 Mar 9.

PMID:
19298280
9.

Development of a quality of life scale for vitiligo.

Şenol A, Yücelten AD, Ay P.

Dermatology. 2013;226(2):185-90. doi: 10.1159/000348466. Epub 2013 May 28.

PMID:
23735515
10.

A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).

Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, Cook SA, Crickx B, Herdman MJ, Frech F, Van Assche D.

Br J Dermatol. 2004 Feb;150(2):274-83.

PMID:
14996098
11.

Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.

Mühleisen B, Büchi S, Schmidhauser S, Jenewein J, French LE, Hofbauer GF.

Arch Dermatol. 2009 Jul;145(7):774-80. doi: 10.1001/archdermatol.2009.121.

PMID:
19620558
12.

Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.

Ongenae K, Dierckxsens L, Brochez L, van Geel N, Naeyaert JM.

Dermatology. 2005;210(4):279-85.

PMID:
15942213
13.

To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index.

Ingordo V, Cazzaniga S, Medri M, Raone B, Digiuseppe MD, Musumeci ML, Romano I, Fai D, Pellegrino M, Pezzarossa E, Di Lernia V, Peccerillo F, Battarra VC, Sirna R, Patrizi A, Naldi L.

Dermatology. 2014;229(3):240-7. doi: 10.1159/000363407. Epub 2014 Oct 25.

PMID:
25358871
14.

Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.

Mazzotti E, Barbaranelli C, Picardi A, Abeni D, Pasquini P.

Acta Derm Venereol. 2005;85(5):409-13.

15.

Effect of vitiligo on self-reported health-related quality of life.

Ongenae K, Van Geel N, De Schepper S, Naeyaert JM.

Br J Dermatol. 2005 Jun;152(6):1165-72.

PMID:
15948977
16.

Life quality assessment among patients with vitiligo: comparison of married and single patients in Iran.

Dolatshahi M, Ghazi P, Feizy V, Hemami MR.

Indian J Dermatol Venereol Leprol. 2008 Nov-Dec;74(6):700.

17.

Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.

He Z, Lu C, Basra MK, Ou A, Yan Y, Li L.

J Eur Acad Dermatol Venereol. 2013 Jan;27(1):109-15. doi: 10.1111/j.1468-3083.2011.04371.x. Epub 2011 Dec 7.

PMID:
22145712
18.

Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles.

Kim DY, Lee JW, Whang SH, Park YK, Hann SK, Shin YJ.

J Dermatol. 2009 Jun;36(6):317-22. doi: 10.1111/j.1346-8138.2009.00646.x. Epub 2009 Apr 28.

PMID:
19500179
19.

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.

Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA.

Health Qual Life Outcomes. 2006 Sep 27;4:71.

20.

The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo.

Komen L, van der Kraaij GE, van der Veen JP, de Rie MA, Wolkerstorfer A.

J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2145-51. doi: 10.1111/jdv.13161. Epub 2015 Apr 13.

PMID:
25868111

Supplemental Content

Support Center